Cross Country Healthcare Stock Beta
| CCRN Stock | USD 10.87 0.53 5.13% |
Cross Country Healthcare fundamentals help investors to digest information that contributes to Cross Country's financial success or failures. It also enables traders to predict the movement of Cross Stock. The fundamental analysis module provides a way to measure Cross Country's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cross Country stock.
Cross |
Cross Country Healthcare Company Beta Analysis
Cross Country's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Cross Country Beta | 0.65 |
Most of Cross Country's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cross Country Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Cross Country Healthcare has a Beta of 0.65. This is 24.42% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Cross Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cross Country's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cross Country could also be used in its relative valuation, which is a method of valuing Cross Country by comparing valuation metrics of similar companies.Cross Country is currently under evaluation in beta category among its peers.
As returns on the market increase, Cross Country's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cross Country is expected to be smaller as well.
Cross Fundamentals
| Return On Equity | -0.004 | ||||
| Return On Asset | 0.0127 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 280.75 M | ||||
| Shares Outstanding | 32.92 M | ||||
| Shares Owned By Insiders | 5.58 % | ||||
| Shares Owned By Institutions | 94.42 % | ||||
| Number Of Shares Shorted | 2.87 M | ||||
| Price To Earning | 5.59 X | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 2.02 B | ||||
| Gross Profit | 627.69 M | ||||
| EBITDA | 129.34 M | ||||
| Net Income | 72.63 M | ||||
| Cash And Equivalents | 279 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 5.27 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 2.67 X | ||||
| Book Value Per Share | 12.24 X | ||||
| Cash Flow From Operations | 248.5 M | ||||
| Short Ratio | 2.69 X | ||||
| Earnings Per Share | (0.05) X | ||||
| Price To Earnings To Growth | 1.81 X | ||||
| Target Price | 15.6 | ||||
| Number Of Employees | 13.13 K | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 340.36 M | ||||
| Total Asset | 679.32 M | ||||
| Retained Earnings | 238.36 M | ||||
| Working Capital | 266.57 M | ||||
| Current Asset | 158.75 M | ||||
| Current Liabilities | 86.05 M | ||||
| Net Asset | 679.32 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cross Country
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.Moving together with Cross Stock
Moving against Cross Stock
| 0.81 | MD | Mednax Inc | PairCorr |
| 0.8 | ECOR | Electrocore LLC | PairCorr |
| 0.79 | ELMD | Electromed | PairCorr |
| 0.71 | DOCS | Doximity | PairCorr |
| 0.71 | VREX | Varex Imaging Corp | PairCorr |
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cross Country Piotroski F Score and Cross Country Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.